EISSN 2148-5607

TJG IS INDEXED IN SCI-EXPANDED AND PUBMED IMPACT FACTOR: 1.4

Turkish Journal of Gastroenterology

35 414 2024

Submission to First Decision = 31 Days

HIGHLY CITED ARTICLES

HBV and HCV are the risk factors in CCA

Tan et al.

Serum resolvin levels in irritable bowel syndrome

Karatay and Gül Utku

Microbial improvement after intervention

Qian et al.

18F-FDGPET/CT in gallbladder carcinoma

Arslan et al.

Bezoar in endoscopy

Gökbulut et al.

Effect of vitamin D on CD40L gene expression in UC

Sharifi et al.

ERCP for acute cholangitis

Khamaysi and Taha

Inborn metabolic causes of fatty liver disease

Yıldız and Sivri

Gastric and small intestinal TSA

Kiremitci et al.

COVID-19 in Hepatology and Liver transplantation

Kabaçam et al.

Editorial

Daily use of consensus interferon: One-year treatment results for chronic hepatitis C patients relapsing ornon-responding to previous interferon

Zeki KARASU ¹ , Ahmet GÜRAKAR ² , Ahmad JAZZAR ³ , Harlan WRİGHT ³

Author Affiliation(s)

1.

Ege Üniversitesi Tıp Fakültesi Gastroenteroloji Bilim Dalı, İzmir

2.

Division of Liver Transplantation Medicine/Hepatology, Nazih Zuhdi Transplantation Institute, Integris Baptist Medical Center, Oklahoma City, OK.

3.

Ege University School of Medicine, Department of Gastroenterology, Bornova, Izmir

Turk J Gastroenterol 2000; 11: 191-195

Keywords : Hepatitis C, konsensus interferon.

Read: 1169 Published: 25 July 2019

Volume 11, Issue 3, September 2000

Previous Article